Author

Gaurav Kharya

Indraprastha Apollo HospitalsORCID 0000-0003-2181-1825Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 3 Research Focus:drug response / drug discovery· 3 Organism:human· 3 Assay:proteomics· 2 Assay:CITE-seq· 1 Approach:diffusion model· 1 Approach:statistical model· 1

Frequent Co-Authors

Amit Kumar SrivastavaiD· 3 shared Nisha ChaudharyiD· 3 shared Raquib AlamiD· 3 shared Sivaprakash RamalingamiD· 3 shared Ulaganathan MabalirajaniD· 3 shared Divya· 2 shared Kashif HusainiD· 2 shared Mohammad HusainiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

Amit Kumar SrivastavaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioengineeringbioRxivPreprintJul 2, 2026

Safe Redosable Low-Immunogenic In Vivo CAR-T Therapy for B Cell Malignancies and Solid Tumors

Raquib Alam, Shantanu Kumar, Rohit Shukla…·Tanveer Ahmad

This paper develops viroVbot, an in vivo CAR-T platform with reduced immunogenicity and safety, showing efficacy in treating multiple myeloma and gastric cancer through sequential redosing.

DOI 10.64898/2026.06.30.735484

humanCITE-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintJan 23, 2026

Reprogramming BCMA-Targeted CAR-T Cells through γ-Secretase Modulation Blocks Antigen Shedding and Extends CAR-T Longevity

Sheetal Sharma Sheetal, Varnit Chauhan, Zahoor Ahmad Bhat…·Tanveer Ahmad

This paper develops SHEDLOCK CAR-T cells that block BCMA shedding, enhancing their cytotoxicity and longevity in multiple myeloma models.

2 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 12, 2025

AI-Guided CAR Designs and AKT3 Degradation Synergize to Enhance Bispecific and Trispecific CAR-T Cell Persistence and Overcome Antigen Escape

Md Sufyan Ansari, Varnit Chauhan, Aashi Singh…·Tanveer Ahmad

This study designs and evaluates AI-optimized CAR-T cells with AKT3 degradation to improve persistence and overcome antigen escape in cancer therapy.

3 citations

humanproteomics

𝕏 PostBluesky